Abstract
Background: Hypoxemia stimulates endothelin-1 (ET-1) secretion. The reduction in alveolar ventilation during sleep is considered sufficient to account for the hypoxemia observed in patients with respiratory diseases. Objective: The aim of this study was to evaluate the arterial ET-1 levels and their relationship with pulmonary hypertension in patients with interstitial lung disease (ILD) during sleep. Methods: We examined 38 patients with ILD using formal polysomnography (electroencephalogram, electrocardiogram, airflow, respiratory muscle movement, oximeter) to detect the presence of nocturnal, nonapneic, oxyhemoglobin desaturation. All patients desaturated below a baseline sleep saturation of 90% for 5 minutes or more, reaching a nadir saturation of at least 85%. Each patient had already undergone right heart catheterization with a Swan-Ganz catheter for measuring hemodynamic parameters. Sampling of arterial blood from a radial artery line for determination of blood gases and ET-1 values was performed simultaneously, after 5 minutes of the first desaturation. Results: At rest, arterial ET-1 levels were higher in ILD patients (1.73 ± 0.37 mgr/mL) than in controls (1.22 ± 0.15 mgr/mL) (p < 0.001). Also, the patients with pulmonary hypertension (Pa > 20 mm Hg) presented significantly higher arterial ET-1 levels (1.86 ± 0.32 mgr/mL) than those without pulmonary hypertension (1.31 ± 0.13 mgr/mL) (p < 0.001). Arterial ET-1 levels were significantly correlated with mean pulmonary arterial pressure (PAP) (r = 0.749, p < 0.001), and arterial oxygen partial pressure (PaO2) (r = 0.79, p < 0.001). At sleep, during desaturation, arterial ET-1 levels significantly increased in all patients (2.46 ± 0.13 mgr/mL) as compared with resting values (p < 0.001). Arterial ET-1 levels were significantly correlated with PAP (r = 0.657, p < 0.001) and PaO2 (r = 0.93, p < 0.001). Conclusions: According to our study, arterial ET-1 is markedly increased in ILD patients, especially in those with pulmonary hypertension.
Similar content being viewed by others
References
Inoue A, Yanagisawa S, Kimura Y, et al. The human endothelin family; three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 1989;86:2863–2867
Giaid A, Michel RP, Stewart DJ, SheppardM, Corria B, Hamid Q. Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis. Lancet 1993;341:1550–1554
Giaid A, Yanagisawa M, Langleben D, et al. Expression of endothelin-1 in lungs of patients with pulmonary hypertension. N Engl J Med 1993;328:1732–1739
Shirakami G, Nakap K, Saito Y, et al. Acute pulmonary alveolar hypoxia increases lung and plasma endothelin-1 levels in conscious rats. Life Sci 1991;48:969–976
Trask CH, Gree EM. Oximeter studies on patients with chronic obstructive emphysema, awake and during sleep. N Engl J Med 1962;266:639–642
Koo KW, Sax DS, Snider GL. Arterial blood gases and pH during sleep in chronic obstructive pulmonary disease. Am J Med 1975;58:663–670
Wynne JW, Block AJ, Hemenway I, HuntLA, Flick MR. Disordered breathing and oxygen desaturation during sleep in patients with chronic obstructive lung disease (COLD). Am J Med 1979;66:573–579
Trakada G, Marangos M, Spiropoulos K. Mechanisms of endothelin-1 elevation in chronic obstructive pulmonary disease patients with nocturnal oxyhemoglobin desaturation. Respiration 2001;68(2):134–139
Francis PW, Muller NL, Gurwitz D, Milligan DW, Levison H, BryanAC. Hemoglobin desaturation: its occurrence during sleep in patients with cystic fibrosis. Am J Dis Child 1980;134:734–740
Stokes DC, McBride JT, Wall MA, Erba G, StriederDJ. Sleep hypoxemia in young adults with cystic fibrosis. Am J Dis Child 1980;134:741–743
Bye PT, Issa F, Berthon-Jones M, SullivanCE. Studies of oxygenation during sleep in patients with interstitial lung disease. Am Rev Respir Dis 1984;129:27–32
Perez-Padilla R, West P, Lertzman M, KrygerMH. Breathing during sleep in patients with interstitial lung disease. Am Rev Respir Dis 1985;132:224–229
Mezon BL, West P, Israels J, Kryger M. Sleep breathing abnormalities in kyphoscoliosis. Am Rev Respir Dis 1980;122:617–621
Guilleminault C, Motta J. Sleep apnea syndrome as a long-term sequela of poliomyelitis. In: Guilleminault C, Dement WC, eds. Sleep Apnea Syndromes. New York, NY: Alan R Liss; 1978:309–315
Douglas NJ, Calverley PM, Leggett RJ, Brash HM, Flenley DC, Brezinova V. Transient hypoxaemia during sleep in chronic bronchitis and emphysema. Lancet 1979;1:1–4
Boysen PG, Block JA, Wynne JW, Hunt LA, Flick MR. Nocturnal pulmonary hypertension in patients with obstructive pulmonary disease. Chest 1979;76:536–542
Fletcher EC, Levin DC. Cardiopulmonary haemodynamics during sleep in subjects with chronic obstructive pulmonary disease: the effect of short- and long-term oxygen. Chest 1984;85:6–14
Flenley DC. Clinical hypoxia: causes, consequences and correction. Lancet 1978;1:542–546
Block AJ, Boyson PG, Wynne JW. The origins of cor pulmonale, a hypothesis. Chest 1979;75:109–110
Rechtshaffen A, Kales A, eds. A Manual of Standarized Terminology, Techniques and Scoring Systems for Sleep Stages of Human Subjects Publication 204, Washington, DC: National Institutes of Health; 1968
Luscher TF. Endothelin [review]. J Cardiovasc Pharmacol 1991;18 (suppl 10):S15–S22
Hay DPW, Henry PJ, Goldie RG. Endothelin and the respiratory system. Trends Pharmacol Sci 1993;14:29–32
Trakada G, Tsourapis S, Marangos M, Spiropoulos K. Arterial and bronchoalveolar lavage fluid endothelin-1 concentration in asthma. Respir Med 2000;10:992–996
Langleben D, Demarchie M, Laporta D, et al. Endothelin-1 in acute lung injury and the adult distress syndrome. Am Rev Respir Dis 1993;148:1646–1650
Lippton HL, Hauth TA, Summer WR, Hyman AL. Endothelin produces pulmonary vasoconstriction and systemic vasodilation. J Appl Physiol 1989;66:1008–1012
Marhewitz BA, Kohan DE, Michael JR. Endothelin-1 synthesis, receptors and signal tranduction in alveolar epithelium: evidence for an autocrine role. Am J Physiol 1995;268:L192–L200
Komuro I, Kurihara H, Sugiyama T, Yoshizumi M, Tahaku F, Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 1988;238:249–252
Trakada G, Spiropoulos K. Arterial endothelin-1 in interstitial lung disease patients with pulmonary hypertension. Monaldi Arch Chest Dis 2001;56:379–383
Bullow K. Respiration and wakefulness in man. Acta Physiol Scand 1963;59:1–110
Douglas NJ, White DP, Pickett CK, Weil JV, Zwillich CW. Respiration during sleep in normal man. Thorax 1982;37:840–844
Catterall JR, Douglas NJ, Carverley PM, et al. Transient hypoxemia during sleep in chronic obstructive pulmonary disease is not a sleep apnea syndrome. Am Rev Respir Dis 1983;128:24–29
Gould GA, Gugger M, Molloy J, Tsara V, ShapiroCM, Douglas NJ. Breathing pattern and eye movement density during REM sleep in humans. Am Rev Respir Dis 1988;138:870–874
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Trakada, G., Nikolaou, E., Pouli, A. et al. Endothelin-1 Levels in Interstitial Lung Disease Patients During Sleep. Sleep Breath 7, 111–118 (2003). https://doi.org/10.1007/s11325-003-0111-y
Issue Date:
DOI: https://doi.org/10.1007/s11325-003-0111-y